|
|
||||||||
Technical Briefs |
United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD
aaddress correspondence to this author at: United States Army Medical Research Institute of Infectious Diseases, 1425 Porter St., Fort Detrick, MD 21702; fax 301-619-2492, e-mail david.norwood{at}amedd.army.mil
Abstract
Background: Rapid detection of biological threat agents is critical for timely therapeutic administration. Fluorogenic PCR provides a rapid, sensitive, and specific tool for molecular identification of these agents. We compared the performance of assays for 7 biological threat agents on the Idaho Technology, Inc. R.A.P.I.D.®, the Roche LightCycler®, and the Cepheid Smart Cycler®.
Methods: Real-time PCR primers and dual-labeled fluorogenic probes were designed to detect Bacillus anthracis, Brucella species, Clostridium botulinum, Coxiella burnetii, Francisella tularensis, Staphylococcus aureus, and Yersinia pestis. DNA amplification assays were optimized by use of Idaho Technology buffers and deoxynucleotide triphosphates supplemented with Invitrogen Platinum® Taq DNA polymerase, and were subsequently tested for sensitivity and specificity on the R.A.P.I.D., the LightCycler, and the Smart Cycler.
Results: Limit of detection experiments indicated that assay performance was comparable among the platforms tested. Exclusivity and inclusivity testing with a general bacterial nucleic acid cross-reactivity panel containing 60 DNAs and agent-specific panels containing nearest neighbors for the organisms of interest indicated that all assays were specific for their intended targets.
Conclusion: With minor supplementation, such as the addition of Smart Cycler Additive Reagent to the Idaho Technology buffers, assays for DNA templates from biological threat agents demonstrated similar performance, sensitivity, and specificity on all 3 platforms.
The following articles in journals at HighWire Press have cited this article:
![]() |
A. B. Herzog, S. D. McLennan, A. K. Pandey, C. P. Gerba, C. N. Haas, J. B. Rose, and S. A. Hashsham Implications of Limits of Detection of Various Methods for Bacillus anthracis in Computing Risks to Human Health Appl. Envir. Microbiol., October 1, 2009; 75(19): 6331 - 6339. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Garnier, J.-C. Gaudin, P. Bensadoun, I. Rebillat, and Y. Morel Real-Time PCR Assay for Detection of a New Simulant for Poxvirus Biothreat Agents Appl. Envir. Microbiol., March 15, 2009; 75(6): 1614 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Rossi, M. Ulrich, S. Norris, D. S. Reed, L. M. Pitt, and E. K. Leffel Identification of a Surrogate Marker for Infection in the African Green Monkey Model of Inhalation Anthrax Infect. Immun., December 1, 2008; 76(12): 5790 - 5801. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Pingle, K. Granger, P. Feinberg, R. Shatsky, B. Sterling, M. Rundell, E. Spitzer, D. Larone, L. Golightly, and F. Barany Multiplexed Identification of Blood-Borne Bacterial Pathogens by Use of a Novel 16S rRNA Gene PCR-Ligase Detection Reaction-Capillary Electrophoresis Assay J. Clin. Microbiol., June 1, 2007; 45(6): 1927 - 1935. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Hill, T. J. Smith, C. H. Helma, L. O. Ticknor, B. T. Foley, R. T. Svensson, J. L. Brown, E. A. Johnson, L. A. Smith, R. T. Okinaka, et al. Genetic Diversity among Botulinum Neurotoxin-Producing Clostridial Strains J. Bacteriol., February 1, 2007; 189(3): 818 - 832. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |